Regulation A · Tier 2 · AIBT
Aibotics, Inc.
Aibotics, Inc. (AIBT) filed a Tier 2 Regulation A offering statement (Form 1-A) on Apr 2, 2025 for up to $5M at $0.01 per security. The SEC qualified the offering on Jul 1, 2025.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $5M
- Offer price
- $0.01
- Security type
- Equity (common or preferred stock)
- Filed
- Apr 2, 2025
- Qualified
- Jul 1, 2025
- Ticker
- AIBT
- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- State
- ID
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Apr 2, 2025
- Final offering circular (253G2)
- All filings on EDGAR CIK 1763329
Other qualified Biotech & pharma Reg A offerings
- Regen BioPharma IncDec 3, 2025 · $1.2M
- Regen BioPharma IncSep 5, 2025 · $2.5M
- Bio-Path Holdings, Inc.May 29, 2025 · $5M
- Turn Therapeutics Inc.Mar 31, 2025 · $18.1M
- Cytonics CorpMar 14, 2025 · $24M
- Medicus Pharma Ltd.Mar 6, 2025 · $12.2M